RecruitingACTRN12620000289910

Case control study of SUDEP (Sudden unexpected death in epilepsy)

Prospective Mutli-centre Case Control Study of SUDEP (Sudden unexpected death in epilepsy), undertaken by the EpiNet Study Group to identify factors that increase or decrease the risk of SUDEP


Sponsor

EpiNet Study Group

Enrollment

1,000 participants

Start Date

Jan 28, 2020

Study Type

Observational

Conditions

Summary

Sudden unexpected death in people with epilepsy (SUDEP) is an under-appreciated tragedy. It has devastating effects on families, friends and colleagues of those who die, and the causes of SUDEP remain unknown. We will conduct an international, multicentre, prospective, case-control study of SUDEP, recruiting participants over four years. Each centre will define a cohort from which cases and controls will be prospectively identified. The cohort will comprise people with epilepsy who have been seen at the centre since a specific date (no earlier than 01/01/2015). Cases will be people with epilepsy from these pre-specified cohorts who have died from definite or probable SUDEP (with or without other co-morbidity), or resuscitated (near) SUDEP if the patient died within 72 hours of the initial collapse. Controls will be people with epilepsy who will be individually-matched by age (±2 years), sex, centre, and enrolled in the cohort at the time of death of the case (with four controls for each case). For each case, three controls will be randomly selected from all patients in the same cohort who meet the above matching criteria, using a random number generator. A fourth control will be a proxy control, who will be a spouse, relative or close friend nominated by a true control, who is randomly selected from the true-control triplet. Use of the proxy controls will allow any measurement error associated with proxy data to be quantified and corrected for. The families of cases, the control patients, and the families of controls patients (i.e. proxy controls), will be interviewed over the phone by a research coordinator or an epilepsy fellow, using a structured questionnaire. Data from the interviews will be recorded in the EpiNet database. This will include demographic data, socio-economic factors, epilepsy factors, usual sleeping arrangements, epilepsy treatments, co-morbidities, medications, alcohol, caffeine, and cigarette use, plus the use of seizure monitors, nocturnal supervision, and/or anti-suffocation pillows. For cases, relatives will be asked about the deceased's sleeping arrangements for the night of death or for the night immediately prior to death, and whether this was different from the typical sleep arrangements. Controls will be asked questions relating to their sleep arrangements on a specific nominated night's sleep (chosen randomly to be in the two weeks prior to the interview). Data neurologists, pathologists, and coroners regarding circumstances around the death, the cause of death, epilepsy and treatment factors will also be recorded if available. The data will be analysed to identify risk factors for SUDEP. Data cleaning will be performed prior to analysis. Odds ratios will be calculated using the Mantel-Haenszel method and logistic regression to control for covariates.


Eligibility

Sex: Both males and females

Plain Language Summary

Simplified for easier understanding

Sudden unexpected death in epilepsy (SUDEP) is a devastating event that strikes people with epilepsy and leaves families searching for answers. The causes of SUDEP remain poorly understood. This international case-control study is working to identify risk factors for SUDEP by carefully comparing the circumstances, sleep arrangements, epilepsy histories, medications, and lifestyle factors of those who have died from SUDEP with those of similar living people with epilepsy. Family members of those who have died from SUDEP, as well as people with epilepsy who are alive (controls), are interviewed by phone using a structured questionnaire. The information gathered covers sleeping arrangements, seizure monitors, medications, alcohol and caffeine use, and other potential factors. The goal is to identify modifiable risk factors that could help prevent future deaths. Participation is open to family members of people who have died from definite or probable SUDEP and who were patients at one of the participating epilepsy centres, as well as to people with epilepsy from those same centres who are being enrolled as controls. Cases must have been identified within 12 months of death.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

We will follow patients with epilepsy, knowing that some of them will die from SUDEP. When this happens, we will identify 3 control subjects from the same cohort as the SUDEP case, matched for age and

We will follow patients with epilepsy, knowing that some of them will die from SUDEP. When this happens, we will identify 3 control subjects from the same cohort as the SUDEP case, matched for age and sex. We will interview a relative / close friend of the Case, and the 3 controls, and review medical notes to gather information about possible risk factors and / or factors that might reduce the risk. We will also interview one proxy control; this will be a relative / close friend of one of the control subjects to match the manner in which we gather information about the SUDEP cases.


Locations(10)

New Zealand

United Kingdom

Italy

United States of America

Norway

Portugal

Hungary

Malaysia

Ireland

Mexico

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12620000289910


Related Trials